|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Dr Reddy's Laboratories Ltd stock downgraded to Sell Candidate
(Updated on Nov 17, 2025)
The Dr Reddy's Laboratories Ltd stock price gained 0.143% on the last trading day (Monday, 17th Nov 2025), rising from $13.94 to $13.96. It has now gained 6 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 2.44% from a day low at $13.71 to a day high of $14.05. The price has risen in 8 of the last 10 days and is up by 4.1% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 104 thousand more shares were traded than the day before. In total, 982 thousand shares were bought and sold for approximately $13.71 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.45% during the next 3 months and, with a 90% probability hold a price between $12.59 and $14.02 at the end of this 3-month period.
RDY Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, October 31, 2025, and so far it has risen 5.04%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dr Reddy's Laboratories Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.03. On a fall, the stock will find some support from the short-term average at $13.77. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Dr Reddy's Laboratories Ltd stock
Dr Reddy's Laboratories Ltd finds support from accumulated volume at $13.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.335 between high and low, or 2.44%. For the last week, the stock has had daily average volatility of 1.72%.
Since the Dr Reddy's Laboratories Ltd has been rising for 6 days in a row, the risk over the next couple of days has increased.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RDY) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Dr Reddy's Laboratories Ltd to open at $13.91, and during the day (based on 14 day Average True Range), to move between $13.83 and $14.09, which gives a possible trading interval of +/-$0.250 (+/-1.81%) up or down from last closing price. If Dr Reddy's Laboratories Ltd takes out the full calculated possible swing range there will be an estimated 1.81% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $13.97 (0.07%) than the support at $13.47 (3.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Dr Reddy's Laboratories Ltd stock A Buy?
Dr Reddy's Laboratories Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.382
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $13.91 ( 0.394%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RDY Performance
Trading levels for RDY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.24 | 2.01% |
| R2 | 14.11 | 1.09% |
| R1 | 14.03 | 0.523% |
| Price | 13.96 | |
| S1 | 13.78 | -1.31% |
| S2 | 13.70 | -1.88% |
| S3 | 13.57 | -2.79% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.58 | 4.44% |
| R2 | 14.20 | 1.72% |
| R1 | 13.97 | 0.0716% |
| Price | 13.96 | |
| S1 | 13.47 | -3.51% |
| S2 | 13.41 | -3.94% |
| S3 | 13.29 | -4.80% |
RDY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 25, 2025 | Jul 25, 2025 | Jul 25, 2025 | $0.0731 | 0.485% |
| 2 | Jul 30, 2024 | Jul 30, 2024 | Jul 30, 2024 | $0.407 | 2.52% |
| 3 | May 11, 2023 | Jul 28, 2023 | Aug 06, 2023 | $0.488 | 3.53% |
| 4 | May 11, 2023 | Jul 07, 2023 | Aug 07, 2023 | $0.488 | 3.53% |
| 5 | May 24, 2022 | Aug 01, 2022 | Aug 12, 2022 | $0.378 | 3.52% |
FAQ
Click here for our free guide on how to buy Dr Reddy's Laboratories Ltd Stock.
Buy RDY